Landscape assessment of the availability of medical abortion medicines in India

• Egile Nagusiak: Priya Karna (Egilea), K. Aparna Sharma (Egilea), Amy Grossman (Egilea), Madhur Gupta (Egilea), Tapas Chatterjee (Egilea), Natalie Williams (Egilea), Ndola Prata (Egilea), Annik Sorhaindo (Egilea), Laurence Läser (Egilea), Ulrika Rehnström Loi (Egilea), Bela Ganatra (Egilea), Pushpa Chaudhary (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2024-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Medical abortion with mifepristone and misoprostol can be provided up to 63 days' gestation in India. This accounts for 67.5 percent of all abortions in the country. We conducted an assessment to determine the availability of medical abortion medicines, specifically the comb...